Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination

European Urology

Volumn 39, Issue 5, 2001, Pages 538-543

  Karazanashvili, Guram ^a   Managadze, Laurent ^b  

^a TBILISI STATE UNIVERSITY   (Georgia)

^b Ministry of Health of Georgia   (United States)

Author keywords

Antibacterial therapy; Prostate cancer; Prostate inflammation; Prostate specific antigen; Screening

Indexed keywords

ANTIINFECTIVE AGENT; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT INFLAMMATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SECRETION; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OFLOXACIN; PALPATION; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0034925230     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052500     Document Type: Article

References (30)

1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
2. Serum prostate-specific antigen as pre-screening test for prostate cancer
3. Screening for prostate carcinoma with prostate-specific antigen
4. Detection of organ-confined prostate cancer increased through prostate-specific antigen-based screening
5. Comparison of digital rectal examination and serum prostate-specific antigen in the early detection of prostate cancer: Results of a multicenter trial of 6,630 men
6. Screening for prostate cancer by digital rectal examination and prostate-specific antigen: Results of prostate cancer awareness week, 1989-1992
7. Cost-effective prostate cancer detection
8. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
9. The value of measurement of serum prostate-specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer
10. The use of prostate-specific antigen density to enhance predictive value of intermediate levels of serum prostate-specific antigen
11. Prostate-specific antigen density: A means of distinguishing benign prostate hypertrophy and prostate cancer
12. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate-specific antigen levels
13. Comparison of percent free prostate-specific antigen and prostate-specific antigen density as methods to enhance prostate-specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate-specific antigen between 4.1 and 10 ng/ml
14. Prostate-specific antigen levels in acute and chronic bacterial prostatitis
15. Prostate-specific antigen density: Correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis
16. The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration
17. Relationship between serum prostate-specific antigen and histological prostatitis in patients with benign prostatic hyperplasia
18. Inflammation in benign prostatic hyperplasia: Correlation with prostate-specific antigen value
19. Prostate-specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and non-human primate
20. Elevated serum prostate-specific antigen related to asymptomatic prostatic inflammation
21. Quality control and standardization of tumor marker tests
22. Prostate fluid inflammation in prostatitis
23. Prostatitis and related disorders
24. Fluoroqinolone anitimicrobial agents
25. Use of quinolones in urinary tract infections and prostatitis
26. The role of chlamydiae in genitourinary disease
27. Isolation of Chlamydia trachomatis from the prostate cells in patients affected by nonacute abacterial prostatitis
28. The role of Chlamydia trachomatis in chronic abacterial prostatitis: A study using ultrasound-guided-biopsy
29. Prostate-specific antigen and prostatitis in men under fifty
30. Impact of prostate benign hyperplasia and prostatic inflammation on the increase of prostate-specific antigen levels